What are the most common side effects of CLL treatment

Common Side Effects of CLL Treatment

Since CLL treatment varies significantly depending on which therapy you're receiving, I'll walk you through the most common side effects by treatment type. This will help you understand what to expect and what to discuss with your care team.

BTK Inhibitors (like ibrutinib, acalabrutinib, zanubrutinib)

These targeted drugs are often used as first-line treatment for CLL. Common side effects include:

• Infections - These are among the most frequent complications because BTK inhibitors can affect your immune system's ability to fight bacteria and viruses
• Bleeding and bruising - You may notice easier bruising or minor bleeding (nosebleeds, bleeding gums)
• Diarrhea - Usually mild to moderate
• Fatigue - General tiredness and low energy
• Muscle or joint pain
• Rash

Venetoclax (a BCL2 Inhibitor)

This drug works differently and has its own side effect profile:

• Tumor Lysis Syndrome (TLS) - This is the most serious potential side effect. When cancer cells die rapidly, they release their contents into your bloodstream, which can damage your kidneys and heart. According to the NCCN Guidelines for CLL, doctors manage this by starting at a very low dose (20 mg) and gradually increasing it over 5 weeks, along with medications to prevent TLS. In clinical trials, when venetoclax was combined with other drugs, TLS rates were less than 1% with proper precautions.
• Neutropenia (low white blood cell count) - This increases infection risk
• Anemia (low red blood cells) - Causes fatigue and shortness of breath
• Thrombocytopenia (low platelets) - Increases bleeding risk
• Infections - More common when combined with other treatments

Chemoimmunotherapy (older approach)

If you're receiving traditional chemotherapy combinations, expect:

• Severe infections - This is the most serious concern
• Low blood counts across all cell types (neutropenia, anemia, thrombocytopenia)
• Nausea and vomiting
• Hair loss
• Mouth sores
• Fatigue
• Increased risk of secondary cancers - A small but real long-term risk

CAR T-Cell Therapy

This newer immunotherapy approach has distinct side effects:

According to the NCCN Guidelines, the most common serious side effects include:

• Cytokine Release Syndrome (CRS) - Occurs in about 85% of patients (though severe grade 3+ CRS in only 9%). This happens when your immune cells release large amounts of inflammatory chemicals. Symptoms include fever, chills, fatigue, and low blood pressure. Doctors manage this with medications like tocilizumab or corticosteroids.
• Neurologic events - About 45% of patients experience these (severe in 18%), including headache, confusion, and dizziness
• Low blood counts - Neutropenia (60%), anemia (52%), and low platelets (41%)
• Infections - Occur in about 17% of patients at severe levels

PI3K Inhibitors (idelalisib, duvelisib)

These are used in specific situations:

• Liver damage (hepatotoxicity) - Requires close monitoring of liver function tests
• Severe diarrhea or colitis - Can be debilitating
• Pneumonitis (lung inflammation)
• Opportunistic infections - Serious infections from organisms that don't usually cause disease
• Febrile neutropenia - Fever combined with very low white blood cells

Managing Side Effects

The good news: Most side effects can be managed effectively. Your care team will:

• Monitor you closely with regular blood tests and check-ins
• Adjust doses if side effects become severe
• Prescribe supportive medications (anti-nausea drugs, antibiotics, growth factors to boost blood cell counts)
• Recommend lifestyle changes (diet modifications, activity adjustments)

Questions to Ask Your Oncologist

Since side effects vary based on YOUR specific treatment plan, ask:

1. Which side effects are most likely with my specific treatment?
2. Which side effects require immediate medical attention, and when should I call you?
3. What medications or supportive care will you provide to manage side effects?
4. How will you monitor me for serious complications like infections or TLS?
5. If I experience severe side effects, can we adjust my treatment plan?

According to the NCCN Guidelines for CLL, your treatment team should be actively managing side effects as part of your overall care plan. Don't hesitate to report any new symptoms—many can be addressed quickly if caught early.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.